Prostatis Group’s JPMorgan Equity Premium Income ETF JEPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-7,019
Closed -$401K – 165
2025
Q1
$401K Sell
7,019
-407
-5% -$23.7K 0.13% 102
2024
Q4
$427K Sell
7,426
-2,757
-27% -$164K 0.12% 111
2024
Q3
$606K Buy
10,183
+323
+3% +$18.6K 0.2% 84
2024
Q2
$559K Sell
9,860
-576
-6% -$32.6K 0.2% 90
2024
Q1
$604K Sell
10,436
-35,322
-77% -$1.99M 0.23% 83
2023
Q4
$2.52M Buy
45,758
+6,783
+17% +$366K 1.05% 29
2023
Q3
$2.14M Buy
38,975
+6,371
+20% +$351K 1.05% 19
2023
Q2
$1.8M Buy
32,604
+12,681
+64% +$693K 0.84% 30
2023
Q1
$1.09M Buy
19,923
+715
+4% +$38.8K 0.57% 46
2022
Q4
$1.05M Buy
19,208
+3,200
+20% +$174K 0.64% 42
2022
Q3
$820K Buy
+16,008
New +$891K 0.95% 29

Other funds holding JEPI

Prostatis Group's JEPI Position: Q2 2025 in Review

Prostatis Group sold out of JPMorgan Equity Premium Income ETF (JEPI) in Q2 2025, closing a stake of 7,019 shares — an estimated $401K sold.

Prostatis Group first reported a position in JEPI in Q3 2022 and held it in 11 quarters. The position peaked at $2.52M in Q4 2023. 1,289 funds tracked by Wall St. Rank hold JEPI as of Q2 2025.

  • Prostatis Group reported no remaining JPMorgan Equity Premium Income ETF position as of Q2 2025 after selling out during the quarter.
  • Prostatis Group sold 7,019 JPMorgan Equity Premium Income ETF shares in Q2 2025, an estimated $401K.
  • Prostatis Group first reported a position in JPMorgan Equity Premium Income ETF in Q3 2022 and held it in 11 quarters.
  • Prostatis Group's JPMorgan Equity Premium Income ETF position peaked at $2.52M in Q4 2023.
  • 1,289 funds tracked by Wall St. Rank held JPMorgan Equity Premium Income ETF as of Q2 2025.

Based on Prostatis Group's 13F filing for Q2 2025, filed 25 Jul 2025.